New discoveries change everything.  How you see things.  How you change your approach.  Your own evolving technique then allows the magic, the breakthrough that challenges the ordinary.  That's why the surgeons who use BioMimetic's rhPDGF-BB orthobiologics are not satisfied with the status quo.  The Company’s lead product, Augment^® Bone Graft, is designed to amplify the body’s natural healing process and eliminate the need for autograft, an invasive secondary surgical procedure requiring bone harvested from one part of the patient's body to be used in the primary surgical site, which often results in patient pain, morbidity, complications and increased operative time and blood loss.  Read more about our advances here, so you too, can reject ordinary.